Genomic testing and Ki-67 Percentage: Two puzzle pieces being undervalued in breast cancer treatment Other Scholarly Work

Wernecke, Chloe, Ortega, Krista, Bontempo, Kelly et al. (2023). Genomic testing and Ki-67 Percentage: Two puzzle pieces being undervalued in breast cancer treatment . CANCER RESEARCH, 83(5), 10.1158/1538-7445.SABCS22-P3-05-44

cited authors

  • Wernecke, Chloe; Ortega, Krista; Bontempo, Kelly; Bentley, Brenna; Hoyer-Kimura, Christina; Beitsch, Peter; Patel, Rakesh; Rosen, Barry; Compagnoni, Gia; Grady, Ian; Brown, Eric; Gold, Lindsay; Whitworth, Pat; Smith, Linda Ann; Reitherman, Richard; Wirga, Mariusz; Cai, Steven; Toan, Nguyen; Traina, Valerie; Holmes, Dennis; Baron, Paul; Krautheim, Brittany; Peled, Anne; Taylor, Walt

authors

publication date

  • March 1, 2023

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • TX, San Antonio

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

volume

  • 83

issue

  • 5